Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Enovix

Enovix Stock Shows Rising Relative Strength, Hitting 80+

Enovix shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 85.

Investors Business Daily

Enovix Stock Sees Another Relative Strength Rating Jump To 93

Enovix Stock Sees Another Relative Strength Rating Jump To 93

Enovix sees its Relative Strength Rating enter the elite 90-plus level.

Investors Business Daily

Enovix Stock Shows Market Leadership, Earns 95 RS Rating

Enovix Stock Shows Market Leadership, Earns 95 RS Rating

Enovix sees its Relative Strength Rating move into the elite 90-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Battery Maker Enovix Hopes To Recharge With New CEO, Strategy

Enovix stock has been on a roller-coaster ride since the battery maker went public less than two years ago.

Investors Business Daily

Check Out What Whales Are Doing With ENVX

Someone with a lot of money to spend has taken a bearish stance on Enovix (NASDAQ:ENVX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022

Enovix Stock Rockets As Next-Generation Battery Maker Hits Big Milestones

Enovix shares rocketed Thursday after the maker of next-generation lithium-ion batteries announced several big milestones.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

11 Industrials Stocks Moving In Thursday's Intraday Session

11 Industrials Stocks Moving In Thursday's Intraday Session

Why Are Enovix Shares Trading Lower Today

Why Are Enovix Shares Trading Lower Today

Cowen analyst Gabe Daoud lowered the price target on Enovix Corp (NASDAQ:ENVX) to $29 from $32 and maintained an Outperform rating on the shares. Daoud notes its revenue funnel grew as management highlighted significant demand/interest with applications emerging across doorbells, GPS, and medical devices. Craig-Hallum analyst Anthony Stoss lowered the price target to $35 (171% upside)…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Gilead Sciences

Edwards Lifesciences

Core Scientific

L3Harris Technologies

Stanley Black Decker

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play